Re-activated adult epicardial progenitor cells are a heterogeneous population molecularly distinct from their embryonic counterparts

Stem Cells and Development

Volumn 23, Issue 15, 2014, Pages 1719-1730

  Bollini, Sveva ^a   Vieira, Joaquim Miguel Nunes ^a   Howard, Sara ^b   Dubè, Karina Natasha ^b   Balmer, Gemma Mary ^b   Smart, Nicola ^a   Riley, Paul Richard ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CELL SURFACE MARKER; CHEMOKINE RECEPTOR CXCR4; HERMES ANTIGEN; STEM CELL ANTIGEN 1; STROMAL CELL DERIVED FACTOR 1; THY 1 ANTIGEN; THYMOSIN BETA4; GREEN FLUORESCENT PROTEIN; LY ANTIGEN; LY6A PROTEIN, MOUSE; MEMBRANE PROTEIN; THYMOSIN; THYMOSIN BETA(4);

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ARTICLE; CELL ACTIVATION; CELL FATE; CELL HETEROGENEITY; CELL POPULATION; CONTROLLED STUDY; EMBRYONIC EPICARDIAL STEM CELL; EMBRYONIC STEM CELL; EPICARDIAL PROGENITOR CELL; EPICARDIUM; FEMALE; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; GENE EXPRESSION; HEART INFARCTION; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MALE; MARKER GENE; MESENCHYMAL STEM CELL; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STEM CELL; ADULT STEM CELL; ANIMAL; C57BL MOUSE; CELL SEPARATION; CYTOLOGY; DRUG EFFECTS; EMBRYOLOGY; GENE EXPRESSION PROFILING; METABOLISM; PERICARDIUM;

ADULT STEM CELLS; ANIMALS; ANTIGENS, CD44; ANTIGENS, LY; ANTIGENS, THY-1; CELL SEPARATION; EMBRYONIC STEM CELLS; FEMALE; GENE EXPRESSION PROFILING; GREEN FLUORESCENT PROTEINS; IMMUNOPHENOTYPING; MEMBRANE PROTEINS; MICE, INBRED C57BL; PERICARDIUM; PHENOTYPE; THYMOSIN;

EID: 84904640712     PISSN: 15473287     EISSN: 15578534     Source Type: Journal    
DOI: 10.1089/scd.2014.0019     Document Type: Article

References (56)

1. Go AS, D Mozaffarian, VL Roger, EJ Benjamin, JD Berry, WB Borden, DM Bravata, S Dai, ES Ford, et al. (2013). Heart disease and stroke statistics: 2013 Update. A report from the American Heart Association. Circulation 127:e6-e245.
2. Braunwald E. (2013). Heart failure: An update. Clin Pharmacol Ther 94:430-432.
3. Hunt SA. (2006). Taking heart-cardiac transplantation past, present, and future. N Engl J Med 355:231-235.
4. Hunt SA and F Haddad. (2008). The changing face of heart transplantation. J Am Coll Cardiol 52:587-598.
5. Fuh E and TJ Brinton. (2009). Bone marrow stem cells for the treatment of ischemic heart disease: A clinical trial review. J Cardiovasc Transl Res 2:202-218.
6. Penn MS, FO Mendelsohn, GL Schaer, W Sherman, M Farr, J Pastore, D Rouy, R Clemens, R Aras and DW Losordo. (2013). An open-label dose escalation study to evaluate the safety of administration of nonviral stromal cell-derived factor-1 plasmid to treat symptomatic ischemic heart failure. Circ Res 112:816-825.
7. Suncion VY, IH Schulman and JM Hare. (2012). Concise review: The role of clinical trials in deciphering mechanisms of action of cardiac cell-based therapy. Stem Cells Transl Med 1:29-35.
8. Kang HJ, HS Kim, SY Zhang, KW Park, HJ Cho, BK Koo, YJ Kim, D Soo Lee, DW Sohn, et al. (2004). Effects of intracoronary infusion of peripheral blood stem-cells mobilised with granulocyte-colony stimulating factor on left ventricular systolic function and restenosis after coronary stenting in myocardial infarction: The MAGIC cell randomised clinical trial. Lancet 363:751-756.
9. Gnecchi M, Z Zhang, A Ni and VJ Dzau. (2008). Paracrine mechanisms in adult stem cell signaling and therapy. Circ Res 103:1204-1219.
10. Maltais S, JP Tremblay, LP Perrault and HQ Ly. (2010). The paracrine effect: Pivotal mechanism in cell-based cardiac repair. J Cardiovasc Transl Res 3:652-662.
11. Mirotsou M, TM Jayawardena, J Schmeckpeper, M Gnecchi and VJ Dzau. (2011). Paracrine mechanisms of stem cell reparative and regenerative actions in the heart. J Mol Cell Cardiol 50:280-289.
12. Nakanishi C, M Yamagishi, K Yamahara, I Hagino, H Mori, Y Sawa, T Yagihara, S Kitamura and N Nagaya. (2008). Activation of cardiac progenitor cells through paracrine effects of mesenchymal stem cells. Biochem Biophys Res Commun 374:11-16.
13. Loffredo FS, ML Steinhauser, J Gannon and RT Lee. (2011). Bone marrow-derived cell therapy stimulates endogenous cardiomyocyte progenitors and promotes cardiac repair. Cell Stem Cell 8:389-398.
14. Bollini S, KK Cheung, J Riegler, X Dong, N Smart, M Ghionzoli, SP Loukogeorgakis, P Maghsoudlou, KN Dube, et al. (2011). Amniotic fluid stem cells are cardioprotective following acute myocardial infarction. Stem Cells Dev 20:1985-1994.
15. Beltrami AP, L Barlucchi, D Torella, M Baker, F Limana, S Chimenti, H Kasahara, M Rota, E Musso, et al. (2003). Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell 114:763-776.
16. Messina E, AL De, G Frati, S Morrone, S Chimenti, F Fiordaliso, M Salio, M Battaglia, MV Latronico, et al. (2004). Isolation and expansion of adult cardiac stem cells from human and murine heart. Circ Res 95:911-921.
17. Matsuura K, T Nagai, N Nishigaki, T Oyama, J Nishi, H Wada, M Sano, H Toko, H Akazawa, et al. (2004). Adult cardiac Sca-1-positive cells differentiate into beating cardiomyocytes. J Biol Chem 279:11384-11391.
18. Bollini S, N Smart and PR Riley. (2011). Resident cardiac progenitor cells: At the heart of regeneration. J Mol Cell Cardiol 50:296-303.
19. Laugwitz KL, A Moretti, J Lam, P Gruber, Y Chen, S Woodard, LZ Lin, CL Cai, MM Lu, et al. (2005). Postnatal isl1 + cardioblasts enter fully differentiated cardiomyocyte lineages. Nature 433:647-653.
20. Chen T, TC Chang, JO Kang, B Choudhary, T Makita, CM Tran, JB Burch, H Eid and HM Sucov. (2002). Epicardial induction of fetal cardiomyocyte proliferation via a retinoic acid-inducible trophic factor. Dev Biol 250:198-207.
21. Zhou B, A von Gise, Q Ma, J Rivera-Feliciano and WT Pu. (2008). Nkx2-5-and Isl1-expressing cardiac progenitors contribute to proepicardium. Biochem Biophys Res Commun 375:450-453.
22. Tomanek RJ. (2005). Formation of the coronary vasculature during development. Angiogenesis 8:273-284.
23. Red-Horse K, H Ueno, IL Weissman and MA Krasnow. (2010). Coronary arteries form by developmental reprogramming of venous cells. Nature 464:549-553.
24. Zhou B, Q Ma, S Rajagopal, SM Wu, I Domian, J Rivera-Feliciano, D Jiang, GA von, S Ikeda, KR Chien and WT Pu. (2008). Epicardial progenitors contribute to the cardiomyocyte lineage in the developing heart. Nature 454:109-113.
25. Cai CL, JC Martin, Y Sun, L Cui, L Wang, K Ouyang, L Yang, L Bu, X Liang, et al. (2008). A myocardial lineage derives from Tbx18 epicardial cells. Nature 454:104-108.
26. Christoffels VM, T Grieskamp, J Norden, MT Mommersteeg, C Rudat and A Kispert. (2009). Tbx18 and the fate of epicardial progenitors. Nature 458:E8-E9; discussion E9-E10.
27. Smart N, CA Risebro, AA Melville, K Moses, RJ Schwartz, KR Chien and PR Riley. (2007). Thymosin beta4 induces adult epicardial progenitor mobilization and neovascularization. Nature 445:177-182.
28. Smart N, CA Risebro, JE Clark, E Ehler, L Miquerol, A Rossdeutsch, MS Marber and PR Riley. (2010). Thymosin beta4 facilitates epicardial neovascularization of the injured adult heart. Ann NY Acad Sci 1194:97-104.
29. Smart N, S Bollini, KN Dube, JM Vieira, B Zhou, S Davidson, D Yellon, J Riegler, AN Price, et al. (2011). De novo cardiomyocytes from within the activated adult heart after injury. Nature 474:640-644.
30. Zhou B and WT Pu. (2012). Isolation and characterization of embryonic and adult epicardium and epicardium-derived cells. Methods Mol Biol 843:155-168.
31. Martin CM, AP Meeson, SM Robertson, TJ Hawke, JA Richardson, S Bates, SC Goetsch, TD Gallardo and DJ Garry. (2004). Persistent expression of the ATP-binding cassette transporter, Abcg2, identifies cardiac SP cells in the developing and adult heart. Dev Biol 265:262-275.
32. Dominici M, K Le Blanc, I Mueller, I Slaper-Cortenbach, F Marini, D Krause, R Deans, A Keating, D Prockop and E Horwitz. (2006). Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8:315-317.
33. Le Blanc K, L Tammik, B Sundberg, SE Haynesworth and O Ringden. (2003). Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex. Scand J Immunol 57:11-20.
34. Zhu H, N Mitsuhashi, A Klein, LW Barsky, K Weinberg, ML Barr, A Demetriou and GD Wu. (2006). The role of the hyaluronan receptor CD44 in mesenchymal stem cell migration in the extracellular matrix. Stem Cells 24:928-935.
35. Sackstein R, JS Merzaban, DW Cain, NM Dagia, JA Spencer, CP Lin and R Wohlgemuth. (2008). Ex vivo glycan engineering of CD44 programs human multipotent mesenchymal stromal cell trafficking to bone. Nat Med 14:181-187.
36. Abbott JD, Y Huang, D Liu, R Hickey, DS Krause and FJ Giordano. (2004). Stromal cell-derived factor-1alpha plays a critical role in stem cell recruitment to the heart after myocardial infarction but is not sufficient to induce homing in the absence of injury. Circulation 110:3300-3305.
37. Davis DR, Y Zhang, RR Smith, K Cheng, J Terrovitis, K Malliaras, TS Li, A White, R Makkar and E Marban. (2009). Validation of the cardiosphere method to culture cardiac progenitor cells from myocardial tissue. PLoS One 4:e7195.
38. Chong JJ, V Chandrakanthan, M Xaymardan, NS Asli, J Li, I Ahmed, C Heffernan, MK Menon, CJ Scarlett, et al. Adult cardiac-resident MSC-like stem cells with a proepicardial origin. Cell Stem Cell 9:527-540.
39. Mellgren AM, CL Smith, GS Olsen, B Eskiocak, B Zhou, MN Kazi, FR Ruiz, WT Pu and MD Tallquist. (2008). Platelet-derived growth factor receptor beta signaling is required for efficient epicardial cell migration and development of two distinct coronary vascular smooth muscle cell populations. Circ Res 103:1393-1401.
40. Smart N, CA Risebro, AA Melville, K Moses, RJ Schwartz, KR Chien and PR Riley. (2007). Thymosin beta-4 is essential for coronary vessel development and promotes neovascularization via adult epicardium. Ann N Y Acad Sci 1112:171-188.
41. Moretti A, L Caron, A Nakano, JT Lam, A Bernshausen, Y Chen, Y Qyang, L Bu, M Sasaki, et al. (2006). Multipotent embryonic isl1 + progenitor cells lead to cardiac, smooth muscle, and endothelial cell diversification. Cell 127:1151-1165.
42. Bu L, X Jiang, S Martin-Puig, L Caron, S Zhu, Y Shao, DJ Roberts, PL Huang, IJ Domian and KR Chien. (2009). Human ISL1 heart progenitors generate diverse multipotent cardiovascular cell lineages. Nature 460:113-117.
43. Kattman SJ, TL Huber and GM Keller. (2006). Multipotent flk-1 + cardiovascular progenitor cells give rise to the cardiomyocyte, endothelial, and vascular smooth muscle lineages. Dev Cell 11:723-732.
44. Martin-Puig S, Z Wang and KR Chien. (2008). Lives of a heart cell: Tracing the origins of cardiac progenitors. Cell Stem Cell 2:320-331.
45. Durocher D, F Charron, R Warren, RJ Schwartz and M Nemer. (1997). The cardiac transcription factors Nkx2-5 and GATA-4 are mutual cofactors. EMBO J 16:5687-5696.
46. Limana F, A Zacheo, D Mocini, A Mangoni, G Borsellino, A Diamantini, MR De, L Battistini, E Vigna, et al. (2007). Identification of myocardial and vascular precursor cells in human and mouse epicardium. Circ Res 101:1255-1265.
47. Bock-Marquette I, A Saxena, MD White, JM DiMaio and D Srivastava. (2004). Thymosin beta4 activates integrinlinked kinase and promotes cardiac cell migration, survival and cardiac repair. Nature 432:466-472.
48. Limana F, C Bertolami, A Mangoni, CA Di, D Avitabile, D Mocini, P Iannelli, MR De, C Marchetti, et al. (2010). Myocardial infarction induces embryonic reprogramming of epicardial c-kit( + ) cells: Role of the pericardial fluid. J Mol Cell Cardiol 48:609-618.
49. Katz TC, MK Singh, K Degenhardt, J Rivera-Feliciano, RL Johnson, JA Epstein and CJ Tabin. (2012). Distinct compartments of the proepicardial organ give rise to coronary vascular endothelial cells. Dev Cell 22:639-650.
50. Bailey B, J Fransioli, NA Gude, R Alvarez Jr., X Zhang, AB Gustafsson and MA Sussman. (2012). Sca-1 knockout impairs myocardial and cardiac progenitor cell function. Circ Res 111:750-760.
51. Ye J, A Boyle, H Shih, RE Sievers, Y Zhang, M Prasad, H Su, Y Zhou, W Grossman, HS Bernstein and Y Yeghiazarians. (2012). Sca-1 + cardiosphere-derived cells are enriched for Isl1-expressing cardiac precursors and improve cardiac function after myocardial injury. PLoS One 7:e30329.
52. Ling L, J Bai, R Gu, C Jiang, R Li, L Kang, A Ferro and B Xu. (2013). Sca-1 + cardiac progenitor cell therapy with cells overexpressing integrin-linked kinase improves cardiac function after myocardial infarction. Transplantation 95:1187-1196.
53. Ruiz-Villalba A, A Ziogas, M Ehrbar and JM Perez-Pomares. (2013). Characterization of epicardial-derived cardiac interstitial cells: Differentiation and mobilization of heart fibroblast progenitors. PLoS One 8:e53694.
54. Zhou B, LB Honor, H He, Q Ma, JH Oh, C Butterfield, RZ Lin, JM Melero-Martin, E Dolmatova, et al. (2011). Adult mouse epicardium modulates myocardial injury by secreting paracrine factors. J Clin Invest 121:1894-1904.
55. Ieda M, T Tsuchihashi, KN Ivey, RS Ross, TT Hong, RM Shaw and D Srivastava. (2009). Cardiac fibroblasts regulate myocardial proliferation through beta1 integrin signaling. Dev Cell 16:233-244.
56. Dimmeler S and A Leri. (2008). Aging and disease as modifiers of efficacy of cell therapy. Circ Res 102:1319-1330.